EA200900338A1 - Вакцины против хламидийной инфекции - Google Patents

Вакцины против хламидийной инфекции

Info

Publication number
EA200900338A1
EA200900338A1 EA200900338A EA200900338A EA200900338A1 EA 200900338 A1 EA200900338 A1 EA 200900338A1 EA 200900338 A EA200900338 A EA 200900338A EA 200900338 A EA200900338 A EA 200900338A EA 200900338 A1 EA200900338 A1 EA 200900338A1
Authority
EA
Eurasian Patent Office
Prior art keywords
chlamyda
infection
vaccines against
proteins
chlamydia trachomatis
Prior art date
Application number
EA200900338A
Other languages
English (en)
Russian (ru)
Inventor
Марк Алдесон
Риа Коулер
Ив Лобе
Жан-Франсуа Л. Майзоннёв
Паскаль Меттен
Петер Пробст
Стивен Рид
Original Assignee
Глаксосмитклайн Байолоджикалс С.А.
Корикса Корпорейшн
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Глаксосмитклайн Байолоджикалс С.А., Корикса Корпорейшн filed Critical Глаксосмитклайн Байолоджикалс С.А.
Publication of EA200900338A1 publication Critical patent/EA200900338A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/118—Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EA200900338A 2006-10-04 2007-10-03 Вакцины против хламидийной инфекции EA200900338A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82809206P 2006-10-04 2006-10-04
PCT/EP2007/060500 WO2008040757A1 (en) 2006-10-04 2007-10-03 Vaccines against chlamydial infection

Publications (1)

Publication Number Publication Date
EA200900338A1 true EA200900338A1 (ru) 2009-10-30

Family

ID=39092594

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200900338A EA200900338A1 (ru) 2006-10-04 2007-10-03 Вакцины против хламидийной инфекции

Country Status (11)

Country Link
US (1) US20100172927A1 (enExample)
EP (1) EP2068916A1 (enExample)
JP (1) JP2010505795A (enExample)
KR (1) KR20090077065A (enExample)
CN (1) CN101522215A (enExample)
AU (1) AU2007304199A1 (enExample)
BR (1) BRPI0719169A2 (enExample)
CA (1) CA2664236A1 (enExample)
EA (1) EA200900338A1 (enExample)
MX (1) MX2009003127A (enExample)
WO (1) WO2008040757A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020061848A1 (en) * 2000-07-20 2002-05-23 Ajay Bhatia Compounds and methods for treatment and diagnosis of chlamydial infection
US20080213264A1 (en) * 1998-12-08 2008-09-04 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US6919187B2 (en) * 2000-04-21 2005-07-19 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US8541007B2 (en) 2005-03-31 2013-09-24 Glaxosmithkline Biologicals S.A. Vaccines against chlamydial infection
EP1981905B1 (en) * 2006-01-16 2016-08-31 THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES Chlamydia vaccine
US8735543B2 (en) 2010-05-28 2014-05-27 Spixia Biotechnology Ab Chimeric MOMP antigen
WO2016081327A2 (en) * 2014-11-21 2016-05-26 Merck Sharp & Dohme Corp. Recombinant expression of chlamydia momp antigen
CN104800841B (zh) * 2015-03-02 2019-04-02 中国农业科学院兰州兽医研究所 牦牛流产衣原体灭活疫苗及其制备方法
CN111735967B (zh) * 2020-08-03 2020-12-22 天津中逸安健生物科技有限公司 一种重组新型冠状病毒疫苗吸附完全性检测方法
US12263213B2 (en) 2023-03-02 2025-04-01 Sanofi Pasteur Compositions for use in treatment of Chlamydia
TW202530245A (zh) * 2023-10-03 2025-08-01 美商Ｖａｘｃｙｔｅ公司 披衣菌疫苗組合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL143531A0 (en) * 1998-12-08 2002-04-21 Corixa Corp Polypeptides containing an antigenic portion of a chlamydia antigen, dna sequences encoding said polypeptides and pharmaceutical compositions and vaccines containing the same
US6919187B2 (en) * 2000-04-21 2005-07-19 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US20020146776A1 (en) * 2000-04-21 2002-10-10 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US20030199438A1 (en) * 2001-04-09 2003-10-23 Shaw Allan Christian Method for identification of proteins from intracellular bacteria
US20040029129A1 (en) * 2001-10-25 2004-02-12 Liangsu Wang Identification of essential genes in microorganisms
ES2312649T3 (es) * 2001-12-12 2009-03-01 Novartis Vaccines And Diagnostics S.R.L. Inmunizacion frente a chlamydia trachomatis.
WO2005027961A2 (en) * 2003-09-23 2005-03-31 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Chlamydia pmpd autotransporter and its role as adhesin
US7892567B2 (en) * 2007-10-01 2011-02-22 Board Of Regents, The University Of Texas System Methods and compositions for immunization against chlamydial infection and disease

Also Published As

Publication number Publication date
AU2007304199A1 (en) 2008-04-10
US20100172927A1 (en) 2010-07-08
KR20090077065A (ko) 2009-07-14
CA2664236A1 (en) 2008-04-10
JP2010505795A (ja) 2010-02-25
EP2068916A1 (en) 2009-06-17
CN101522215A (zh) 2009-09-02
MX2009003127A (es) 2009-06-26
BRPI0719169A2 (pt) 2014-02-04
WO2008040757A1 (en) 2008-04-10

Similar Documents

Publication Publication Date Title
EA200900338A1 (ru) Вакцины против хламидийной инфекции
UA97943C2 (ru) Вакцина против инфекции chlamydia
MX2009003325A (es) Vacuna que comprende un adyuvante de emulsion de aceite en agua.
UA100507C2 (ru) Предупреждение и лечение субклинической формы болезней, вызываемых цирковирусом свиней (pcvd)
WO2006065553A3 (en) Glycoconjugate vaccines containing peptidoglycan
NZ595689A (en) Compositions for immunising against staphylococcus aureus
EA200901078A1 (ru) Конъюгаты синтетических агонистов tlr и их применение
WO2007120673A3 (en) Immunogenic wt-1 peptides and methods of use thereof
WO2008071898A3 (fr) Appareil de traitement par emission de flashs lumineux avec dispositif d'anti-eblouissement
CY1110046T1 (el) Γαβοξαδολη για τη θεραπεια της καταθλιψης και αλλων συναισθηματικων διαταραχων
EA200802166A1 (ru) Стабильная фармацевтическая композиция с защитным действием от раздражения (варианты), способ ее получения и способ лечения кальций-миметиком с ее помощью
EA200970529A1 (ru) Антивирусная композиция и способ ее применения
BRPI0508451A (pt) método de tratamento de linfoma não-hodgkin em um mamìfero, usos de uma combinação de cci-779 e rituximab e de uma combinação de um inibidor de mtor e rituximab, produtos contendo cci-779 e rituximab e um inibidor mtor e rituximab, embalagem farmacêutica, e, composição farmacêutica
JP2010505795A5 (enExample)
WO2007150008A3 (en) Polypeptides from african swine virus as vaccines for preventive and therapeutic use
WO2006042149A3 (en) Determining and reducing immunoresistance to botulinum toxin therapy using botulinum toxin a peptides
BRPI0819839A2 (pt) Uso de anticorpo humano capaz de neutralizar o vírus da hepatite b para a prevenção ou tratamento da infecção por vírus da hepatite b
BRPI0910884A2 (pt) composição imunogênica, método para tratar ou prevenir infecção ou doença estafilocócicas, e, uso de uma composição imunogênica.
WO2008057158A3 (en) Novel neutralizing immunogen (nimiv) of rhinovirus and its use for vaccine applications
BRPI0612005A2 (pt) agente profilático ou terapêutico, composição oftalmológica, uso de selenoproteína p, e, método de prevenção/tratamento de uma doença corneal/conjuntival
WO2008153772A3 (en) Chlamydia vaccine comprising htra polypeptides
MX2012004133A (es) Composiciones que comprenden adyuvante, macrolido y antigeno proteico y procedimientos de uso de las mismas.
SG147465A1 (en) Vaccine
BRPI0410967A (pt) compostos, composições e seus usos para o tratamento de infecções por vìrus da famìlia flaviviridae
WO2008044149A3 (en) Shigella ipad protein and its use as a vaccine against shigella infection